HomeAnalytics 4 Life

Analytics 4 Life

Analytics 4 Life to Present New Clinical Data on Novel Cardiac Imaging Technology Using Machine-Learned Algorithms at the Transcatheter Cardiovascular Therapeutics 2017 Scientific Symposium

"We are encouraged by these initial results which suggest that our cardiac imaging technology has clinically significant utility in assessing coronary artery disease (CAD), without the need for radiation, exercise or pharmacologic stress," said Don Crawford, CEO, Analytics 4 Life. "Conventional CAD detection pathways may be less accurate in specific populations, such as obese, elderly and female patients, but these early results show a promising potential for alternative technology."